Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03472300
Recruitment Status : Active, not recruiting
First Posted : March 21, 2018
Last Update Posted : May 4, 2020
Sponsor:
Information provided by (Responsible Party):
Henning Bliddal, Frederiksberg University Hospital

Brief Summary:
Although knee pain is prevalent among community-dwelling older adults, little is known about how people in general handle their pain. We will conduct a survey to explore how knee pain affects people's lives and which treatments or self-management strategies they have chosen (or are being offered), and how these interact concerning pain reduction and maintenance of function.

Condition or disease Intervention/treatment
Knee Osteoarthritis Survey, Family Life Complementary Therapies Pain Other: Survey about knee pain and treatment

Detailed Description:

Although knee pain is prevalent among community-dwelling older adults and frequently leads to consultation in primary care, little is known about how people in general manage their knee pain.

Treatments of knee osteoarthritis include a variety of non-pharmaceutical, medical, and surgical interventions with highly individual and inconsistent results and with the possible exception of a longer lasting weight reduction, none of the non-surgical treatments have been able to demonstrate long-lasting effect on pain or disability.

It is well recognised that patient participation in handling of disease creates better compliance and satisfaction with pharmacological treatment.

Another option for taking active part in self-management is the use of complementary and alternative medicine (CAM). despite their popularity and effect, there is currently no overview of the actual extent of CAMs used for knee pain and disability at a population level, and most CAMs remain to be studied scientifically for efficacy.

The incidence of knee OA shows a steep increase at age above 60 years. Furthermore, after this age an increasing prevalence of disablement to knee trouble is encountered. To prevent this development, measures must be sought to alter the course of knee OA.

By asking people about how knee pain affects their life, which treatments or self-management strategies they have chosen (or are being offered), and how these interact for the reduction of pain and maintenance of function, new knowledge will be gained about the preferences and perceived effectiveness of treatments at large. The information gained will enable the prioritising of research on interventions to be tested and will align this with the primary concerns and interests of the population. This will subsequently lead to better guidance of patients by the health care providers, and will aid decision makers in choosing feasible health care policies and strategies.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 9600 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals From Frederiksberg Municipality - A Prospective Cohort Study
Actual Study Start Date : September 5, 2018
Estimated Primary Completion Date : October 21, 2028
Estimated Study Completion Date : October 21, 2028

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Frederiksberg Citizens
All citizen in the Frederiksberg Community aged 60-69
Other: Survey about knee pain and treatment
All citizens are surveyed to describe the prevalence of knee pain in a danish community.




Primary Outcome Measures :
  1. Self-disclosed knee trouble/pain [ Time Frame: 1 Year ]
    Population incidence of self-disclosed knee trouble/pain


Secondary Outcome Measures :
  1. Self-disclosed knee trouble/pain [ Time Frame: Annually for 10 years ]
    Population incidence of self-disclosed knee trouble/pain

  2. Knee injury and Osteoarthritis Outcome Score (KOOS) [ Time Frame: Annually for 10 years ]
    Actual KOOS score and scores over time (respondents who report having knee pain)

  3. Brief Illness Perception Questionnaire (IPQ-B) [ Time Frame: Annually for 10 years ]

    Actual IPQ-B score and scores over time (respondents who report having knee pain). Generic questionnaire developed to measure illness perception. The IPQ-B contains eight items and one causal scale. Items 1-8 are rated using a 0-to-10 response scale, item 9 is a memo field. Five of the items assess cognitive illness representations: consequences (Item 1), timeline (Item 2), personal control (Item 3), treatment control (Item 4), and identity (Item 5). Two of the items assess emotional representations: concern (Item 6) and emotions (Item 8). One item assesses illness comprehensibility (Item 7).

    A low score on items number 1,2,5,6 and 8 indicates that the illness is perceived as benign while a low score on the items 3, 4 and 7 indicates that the illness is perceived as threatening. By reversing these three items it is possible to compute an overall score. A higher score reflects a more threatening view of the illness.


  4. EQ-5D [ Time Frame: Annually for 10 years ]
    Actual EQ-5D score and scores over time (all respondents)

  5. Treatments of all kinds [ Time Frame: Annually for 10 years ]
    To estimate the use of treatments of all kinds (both in the "established" health care system and as self-management), including use of non-pharmacological treatments

  6. Influence of treatments (longitudinal) [ Time Frame: Annually for 10 years ]
    Influence of treatments and their combination on use of health care system including surgical procedures.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years to 69 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
The study population will comprise the sample of all elderly individuals 60-69 years old, living in the Frederiksberg municipality (central part of Copenhagen) Denmark
Criteria

Inclusion Criteria:

  • Between 60-69 years of age
  • Citizen in the Community of Frederiksberg

Exclusion Criteria:

• No formal exclusion criteria but unability to understand/answer our questionnaire is per se an exclusion criteria


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03472300


Locations
Layout table for location information
Denmark
the Parker Institute, Bispebjerg-Frederiksberg Hospital
Frederiksberg, Danmark, Denmark, 2000
Sponsors and Collaborators
Frederiksberg University Hospital
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Henning Bliddal, Head of the Parker Institute, Frederiksberg University Hospital
ClinicalTrials.gov Identifier: NCT03472300    
Other Study ID Numbers: FrbCohort-01
First Posted: March 21, 2018    Key Record Dates
Last Update Posted: May 4, 2020
Last Verified: May 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Henning Bliddal, Frederiksberg University Hospital:
Knee Osteoarthritis
pain
Complementary Therapies
Survey
questionnaire
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases